BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2002
View Archived Issues
Adenosine A3 receptor agonists: a novel class of anticancer agents
Read More
Antagonism of the glucocorticoid receptor as a possible approach to Alzheimer's disease
Read More
Glucagon antagonists or inverse agonists identified at Novo Nordisk and Agouron
Read More
Colesevelam improves LDL particle size distribution in moderate hypercholesterolemia
Read More
Breakthrough AIDS treatment ready for phase II clinical trials
Read More
Carrageenan-based microbicide PC-710 described at AIDS conference
Read More
NR2B-selective NMDA antagonists for the treatment of pain syndromes
Read More
Inspire presents melatonin analogues with IOP-reducing properties
Read More
Bladder-selective antimuscarinic agent from Roche in development for overactive bladder
Read More
Effective and safe new antithrombotic presented by Pfizer at IUPHAR 2002
Read More
SSR-182289: novel oral thrombin inhibitor with high potency and selectivity
Read More
Early clinical data discussed for the HIV integrase inhibitor S-1360
Read More
U.S. research group presents new antitumor camptothecins
Read More
Prostaglandin IP antagonists and their use in pain, etc.
Read More
Data from preclinical studies support further development of PA-344B
Read More
Immune type-selective proteasome inhibitors identified at Kyorin
Read More
Wyeth claims dual 5-HT1A/SERT modulators
Read More
New anxiolytic/antidepressant agents under study at Ortho-McNeil
Read More
Novel CRF antagonists in early development at Neurocrine Biosciences
Read More
PRO-2000 proves safe, achieves potentially protective levels in women
Read More
Enzyme replacement therapy for Fabry's disease to be reviewed by advisory committee
Read More
Large Scale Biology enters collaboration for developing plant-derived vaccines
Read More
Amgen and Immunex grant license to Regeneron
Read More
AstraZeneca completes mutual recognition procedure for pediatric use of Symbicort Turbuhaler
Read More
